Globally, oral cancer is the sixth most common cancer. In India it is the most common cancer in men and third most common cancer in women, the tongue is the most common location and accounts for approximately 25% to 40% of oral cancers. The incidence of carcinoma tongue is higher in an older age group, especially men, with a long history of tobacco use and alcohol consumption. Recently, however, there has been an increase in the incidence of oral cancer in a younger population especially in women who have not been exposed to the conventional risk factors. Although tongue cancer is not one of the most common cancers in women, this increase in occurrence has raised concern. This study intends to find out the patterns of presentation and treatment outcome in female patients who were diagnosed with carcinoma tongue at our center. This was a retrospective analysis to describe the clinic pathological characteristics and to find out the treatment outcome in female patients with carcinoma tongue treated at our center during the period 1st January 2015 to 31st December 2020. All cases of histopathologically proven tongue cancers were included in our study. The quantitative variables were summarized using descriptive statistics and the qualitative variables were summarized using number and percentages. The Kaplan- Meier method was used to find out the overall and disease free survival. The data was analyzed using statistical software SPSS version 20. A total of 295 females were diagnosed with carcinoma tongue during the study period. The median age of the study population was 62 years.45% patients had a history of chewing tobacco.25%patients had family history of malignancy. 43% of patients had comorbidities. The most common site of involvement was the lateral border in 82% of cases.42% had well differentiated squamous cell carcinoma histology.71% of patients presented with ulcer and pain.62 % of patients presented with stage III and stageIV disease. 52% patients underwent radical intent treatment.21% patients underwent palliative intent radiation or chemotherapy treatment and 27% patients did not undergo any treatment. Median follow up was 36.9 months. The three year DFS was 71% and 3-year OS was 76.5%. The 3 year DFS and OS for stage I disease was 80.3% and 80.5%. For stage II it was 88.7% and 95.8%. For stage III it was 69.2% and 69.8% and for stage IV it was 54.6% and 62.6% respectively. Oral tongue cancer presents in advanced stages and carries poor prognosis. Its increasing incidence in females is a growing concern. Our study showed that the clinicopathological profile and outcomes were similar to the literature data. More studies are needed to find out if there is any difference in treatment outcome with the male counterparts. Also studies are needed to find out the mechanisms involved in carcinoma development in non-habituate females.
Keywords: Clinical outcome, Female tongue cancer.
Full HTML:
Hilly O, Shkedy Y, Hod R, Soudry E, Mizrachi A, Hamzany Y, et al. Carcinoma of the oral tongue in patients younger than 30 years: comparison with patients older than 60 years. Oral Oncol. 2013;49(10):987-90.
Shah JP, Gil Z. Current concepts in management of oral cancer--surgery. Oral Oncol. 2009;45:394–401. doi: 10.1016/j.oraloncology.2008.05.017.
Pulte D, Brenner H. Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. Oncologist. 2010;15:994–1001. doi: 10.1634/theoncologist.2009-0289.
Zanoni DK, Montero PH, Migliacci JC, Shah JP, Wong RJ, Ganly I, et al. Survival outcomes after treatment of cancer of the oral cavity (1985-2015) Oral Oncol. 2019;90:115–21. doi: 10.1016/j.oraloncology.2019.02.001.
5.Choi SW, Moon EK, Park JY, Jung KW, Oh CM, Kong HJ, et al. Trends in the incidence of and survival rates for oral cavity cancer in the Korean population. Oral Dis. 2014; 20:773–9. doi: 10.1111/odi.12251.
Bello IO, Soini Y, Salo T. Prognostic evaluation of oral tongue cancer: means, markers and perspectives (II) Oral Oncol. 2010; 46:636–43. doi: 10.1016/j.oraloncology.2010.06.008.
van Dijk BA, Brands MT, Geurts SM, Merkx MA, Roodenburg JL. Trends in oral cavity cancer incidence, mortality, survival and treatment in the Netherlands. Int J Cancer. 2016;139:574–83. doi: 10.1002/ijc.30107
Tota, J.E.; Anderson, W.F.; Coffey, C.; Califano, J.; Cozen, W.; Ferris, R.L.; John, M.S.; Cohen, E.E.; Chaturvedi, A.K. Rising incidence of oral tongue cancer among white men and women in the United States, 1973–2012. Oral Oncol.2017, 67, 146–152.
S. C. Patel, W. R. Carpenter, S. Tyree et al., “Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years,” Journal of Clinical Oncology, vol. 29, no. 11,pp. 1488–1494, 2011.
Iype EM, Pandey M, Mathew A, Thomas G, Sebastian P, Nair MK. Oral cancer among patients under the age of 35 years. J Postgrad Med 2001;47:171-76.
Agrawal KH, Rajderkar SS. Clinicoepidemiological profile of oral cancer: A hospital based study. Indian J Community Health 2012;24(2):80-85.
Sunilkumar, Saina; Bindu, T; Kumbakara, Ratheesan; Balasubramanian, Satheesan1. Patterns of cancer at a tertiary cancer center in Kerala, India, based on 10-years of hospital-based cancer registry data: A retrospective observational study. Cancer Research, Statistics and Treatment 7(2):p 185-192, Apr–Jun 2024. | DOI: 10.4103/crst.crst_375_23
Jones JB, Lampe HB, Cheung HW. Carcinoma of the tongue in young patients. J Otolaryngol 1989; 18: 105– 108.CAS PubMed Web of Science® Google Scholar
Byers RM. Squamous cell carcinoma of the oral tongue in patients less than thirty years of age. Am J Surg 1975; 130: 475– 478.View CAS PubMed Web of Science® Google Schola
Clark RW, Stell PM. Squamous carcinoma of the head and neck in the young adults. Clin Otolaryngol 1992; 17: 18– 23.View PubMed Web of Science® Google Scholar
Gangane N, Chawla S, Anshu, Gupta SS, Sharma SM. reassessment of risk factors for oral cancer. Asian Pacific J Cancer Prev 2007; 8:243-48.
Saraswathi TR, Ranganathan K, Shanmugam S, et al. Prevalence of oral lesions in relation to habits: Cross-sectional study in South India. Indian J Dent Res 2006; 17:121-25.
Mehrotra R, Singh M, Kumar D, et al. Age specific incidence rate and pathological spectrum of oral cancer in Allahabad. Indian J Med Sci 2003; 57:400-04.
Ghani WMN, Ramanathan A, Prime SS, Yang Y-H, Razak IA, Abdul Rahman ZA, et al. Survival of Oral Cancer Patients in Different Ethnicities. Cancer Invest. 2019;37(7):275–87. Pmid:31307249
Toporcov TN, Znaor A, Zhang ZF, Yu GP, Winn DM, Wei Q, Vilensky M, Vaughan T, Thomson P, Talamini R, Szeszenia-Dabrowska N. Risk factors for head and neck cancer in young adults: a pooled analysis in the INHANCE consortium. International journal of epidemiology. 2015 Feb 1;44(1):169-85.
Garavello W, Foschi R, Talamini R, la Vecchia C, Rossi M, Dal Maso L, Tavani A, Levi F, Barzan L, Ramazzotti V, Franceschi S, Negri E. Family history and the risk of oral and pharyngeal cancer. Int J Cancer. 2008;122(8):1827–1831. doi: 10.1002/ijc.23199.
Najeeb T. Clinicopathological presentation of tongue cancers and early cancer treatment. J Coll Physicians Surg Pak. 2006 Mar;16(3):179-82. PMID: 16542596.
Albuquerque R, López-López J, Marí-Roig A, Jané-Salas E, Roselló-Llabrés X, Santos JR. Oral Tongue Squamous Cell Carcinoma (OTSCC): Alcohol and Tobacco Consumption versus Non-Consumption. A Study in a Portuguese Population. Braz Dent J. 2011;22:517–521.
Falaki F, Dalirsani Z, Pakfetrat A, Falaki A, Saghravanian N, Nosratzehi T, Pazouki M. Clinical and histopathological analysis of oral Squamous cell carcinoma of young patients in Mashhad, Iran: A retrospective study and review of literatures Med Oral Patol Oral Cir Bucal. 2011 Jul 1;16:e473–7
Agarwal, AK, Sethi A, Sareen D, Dhingra S. Oral and oropharyngeal squamous cell carcinoma in our population: The clinic-pathological and morphological description of 153 cases. Int. J. Morphol. 2011;29:686–93.
Selvamani M, Yamunadevi A, Basandi PS, Madhushankari GS. Prevalence of oral squamous cell carcinoma of tongue in and around Davangere, Karnataka, India: A retrospective study over 13 years. J Pharm Bioallied Sci. 2015 Aug;7(Suppl 2):S491-4. doi: 10.4103/0975-7406.163511. PMID: 26538904; PMCID: PMC4606646.
Gadbail AR, Chaudhary M, Gawande M, Hande A, Sarode S, Tekade SA, et al. Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis. J Oral Pathol Med. 2017;46(6):448–53. Pmid:28129456
Chu KP, Shema S, Wu S, Gomez SL, Chang ET, Le QT. Head and neck cancer?specific survival based on socioeconomic status in Asians and Pacific Islanders. Cancer. 2011;117(9):1935–45. Pmid:2150977
Ghani WMN, Ramanathan A, Prime SS, Yang Y-H, Razak IA, Abdul Rahman ZA, et al. Survival of Oral Cancer Patients in Different Ethnicities. Cancer Invest. 2019;37(7):275–87. Pmid:31307249
Mosleh-Shirazi, M., Mohammadianpanah, M., & Mosleh-Shirazi, M. (2009). Squamous cell carcinoma of the oral tongue: A 25-year, single institution experience. The Journal of Laryngology & Otology,123(1), 114-120. doi:10.1017/S0022215108003186
Mroueh R, Haapaniemi A, Saarto T, Grönholm L, Grénman R, Salo T, Mäkitie AA. Non-curative treatment of patients with oral tongue squamous-cell carcinoma. Eur Arch Otorhinolaryngol. 2019 Jul;276(7):2039-2045. doi: 10.1007/s00405-019-05456-y. Epub 2019 May 8. PMID: 31069467; PMCID: PMC6581924.
Ukrani, R.D., Danish, M.H., Ikram, M. et al. Survival of oral tongue cancer in low middle-income country: a cohort study. Egypt J Otolaryngol 39, 70 (2023). https://doi.org/10.1186/s43163-023-00435-x
Listl S, Jansen L, Stenzinger A, Freier K, Emrich K, Holleczek B, et al. Survival of patients with oral cavity cancer in Germany. PLoS One. 2013;8(1).
Rogers SN, Brown JS, Woolgar JA, Lowe D, Magennis P, Shaw RJ, et al. Survival following primary surgery for oral cancer. Oral Oncol. 2009;45(3):201–11. 10.1016/j.oraloncology.2008.05.008.
Siegel, R. L., Miller, K. D., & Jemal, A. (2016). Cancer statistics, 2016. CA Cancer J Clin, 66(1), 7–30. do: 10.3322/caac.21332.
Zini A, Czerninski R, Sgan-Cohen HD. Oral cancer over four decades: epidemiology, trends, histology, and survival by anatomical sites. J Oral Pathol Med. 2010;39(4):299–305. doi: 10.1111/j.1600-0714.2009.00845